Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study

The introduction of direct antiviral drugs (DAAs) has revolutionized the treatment of hepatitis C virus (HCV), with sustained virologic response rates of more than 90% in most patient populations. [1] Pawlotsky J.-M. New hepatitis C therapies: the toolbox, strategies, and challenges. Gastroenterology. 2014; 146: 1176-1192 Abstract Full Text Full Text PDF PubMed Scopus (430) Google Scholar However, it has been suggested that interferon-free HCV...